Role of peroxisome proliferation in leptin resistance
Project Number7R01DK097566-09
Former Number5R01DK097566-08
Contact PI/Project LeaderDIANO, SABRINA
Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
Previous data from our and others' laboratories (Andrews et al., 2008; Benani et al., 2007; Anderson et al.,
2009; Jaillard et al., 2009; Campanucci et al., 2010; Diano et al., 2011; Dietrich et al., 2013; Long et al.,
2014) showed that reactive oxygen species (ROS) generation is not merely a by-product of substrate
oxidation, but it plays a crucial role in modulating cellular responses involved in the regulation of energy
metabolism. We have observed that suppression of ROS levels diminish pro-opiomelanocortin (POMC) cell
activation and promote the activity of neuropeptide Y- (NPY)/ agouti related peptide- (AgRP) neurons and
feeding, whereas ROS activates POMC neurons and reduces feeding. Mitochondria are primary organelles
in the generation of ROS and mitochondrial dynamics, i.e. fission and fusion, alters the production of
mitochondrial ROS, with mitochondrial fission decreasing and mitochondrial fusion increasing ROS
production. Furthermore, uncoupling protein 2 (UCP2), a mitochondrial protein inducing proton leak and
highly expressed in the arcuate nucleus, reduces ROS production. Our published (Coppola et al., 2007;
Andrews et al., 2008; Diano et al., 2011; Dietrich et al., 2013; Long et al., 2014) and preliminary data
generated during this funding period showed that mitochondrial size in AgRP and POMC neurons changes
according to the metabolic state of the organism: while during negative energy balance, characterized by
increased AgRP and decreased POMC neuronal activities, mitochondrial size decreases (fission), during
positive energy balance (fed state) mitochondrial size increases in AgRP and POMC (fusion). Thus, we
hypothesize that the activity levels of POMC and NPY/AgRP neurons require UCP2-mediated mitochondrial
dynamics. UCP2-induced mitochondrial fission, by decreasing ROS production, inhibits POMC neurons
while activates NPY/AgRP neurons. Furthermore, we hypothesize that fuel availability drives mitochondrial
dynamics a more specifically low glucose levels drives fission, while high glucose availability drives fusion.
To test our hypothesis that fuel regulation of UCP2-mediated mitochondrial dynamics is an
important component in the central regulation of metabolism, 3 Aims are proposed:
Aim 1 will test the hypothesis that UCP2-mediated mitochondrial fission inactivates POMC neurons.
Aim 2 will test the hypothesis that UCP2-mediated mitochondrial fission activates NPY/AgRP
neurons.
Aim 3 will test the hypothesis that fuel availability drives mitochondrial dynamics in AgRP and
POMC neurons. Specifically we hypothesize that low glucose and high fatty acid environment
(negative energy balance) drives fission, while high glucose availability drives fusion.
The execution of these studies will deliver novel insights into central regulation of whole body glucose
metabolism and offer novel avenues to combat diabetes by targeting brain mitochondrial dynamics.
Public Health Relevance Statement
To understand the etiology of metabolic disorders, including obesity and type II diabetes,
it is essential that we gain better insight into the mechanisms used by the central
nervous system to regulate neuronal circuitry related to glucose metabolism. The
experiments proposed in this application will unmask the role of UCP2 and mitochondrial
dynamics in the central regulation of energy and glucose homeostasis and will help us to
better develop strategy for the treatment of obesity and type II diabetes.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
621889815
UEI
QHF5ZZ114M72
Project Start Date
01-September-2020
Project End Date
31-May-2022
Budget Start Date
01-September-2020
Budget End Date
31-May-2022
Project Funding Information for 2020
Total Funding
$337,540
Direct Costs
$208,358
Indirect Costs
$129,182
Year
Funding IC
FY Total Cost by IC
2020
National Institute of Diabetes and Digestive and Kidney Diseases
$337,540
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R01DK097566-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01DK097566-09
Patents
No Patents information available for 7R01DK097566-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01DK097566-09
Clinical Studies
No Clinical Studies information available for 7R01DK097566-09
News and More
Related News Releases
No news release information available for 7R01DK097566-09
History
No Historical information available for 7R01DK097566-09
Similar Projects
No Similar Projects information available for 7R01DK097566-09